I heard you and other speaker on the Diane Rehm show ysedertay. One of the speakers was cut off by the n of the program. He mentioned something about Plavix and cumodin. I have an urgent interest in these medications. I was on both once for 2 weeks and subsequently for 4 weeks. The sequence was separated by a surgery and reinitiated by another surgery After the second surgery I refused to resume the Plavix..My question: I developed significant bruising- they appeared overnight.Two in my elbow area. Each was the size of a goose egg surround ed by bruising the circumference of an orange. In the middle of the egg was a knot the size a pigeons egg. I also had one on my rib cage and the back of my knee.I am two weeks out of the surgery and not on plavix, only cumidin.The neurosurgeon, internist and ER doctor did not know what to attribute this pattern of bruising . I called the FDA and the line goes dead after two rings.I am happy to say no new one has arisen since I discontinued the plavix.
Marblehead-based Medicinal Genomics LLC has produced what it claims is the largest known gene collection of two forms of Cannabis, and has made the data available to researchers looking at the medicinal properties of the plant. Medicinal Genomics said it has sequenced the entire genome of Cannabis sativa and Cannabis indica, and that the DNA purification was performed at the company’s research facility in Amsterdam, while the sequencing was conducted by several service providers. The company said that, previously, only two million bases of Cannabis sequence had been deposited in GenBank, a sequence database provided by the National Center for Biotechnology Information (NCBI). In comparison, Medicinal Genomics has privately sequenced over 131 billion bases of sequence. Medicinal Genomics has published the raw reads from Cannabis sativa on Amazon’s EC2, a public cloud computing service, giving the scientific community access to conduct further research. The company said the Cannabis indica genome sequence will be made available on EC2 in a few weeks. The company also plans to make the genome annotations available through an iPad application in the fall. Medicinal Genomics said in a press release that researchers will be able to identify non-psychoactive compounds or enzyme pathways to realize the therapeutic benefits of Cannabis, including the plant’s anti-cancer properties.
Return to top of page
Copyright © 2013 · Corporate Theme on Genesis Framework · WordPress · Log in